Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – Jordan, 2020-02-04 11:28 (872 d 18:31 ago) – Posting: # 21141
Views: 2,742

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

UA Flag
Activity
 Admin contact
22,167 posts in 4,645 threads, 1,572 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Sunday 06:59 CEST (Europe/Vienna)

The person interested in success has to learn
to view failure as a healthy, inevitable part
of the process of getting to the top.    Joyce Brothers

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5